3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
313
Lung Neoplasms
204
Small Cell Lung Carcinoma
56
Colorectal Neoplasms
55
Neoplasms
41
Ovarian Neoplasms
40
Melanoma
38
Pancreatic Neoplasms
35
Breast Neoplasms
34
Neoplasm Metastasis
28
Stomach Neoplasms
26
Squamous Cell Carcinoma of Head and Neck
25
Carcinoma, Renal Cell
23
Endometrial Neoplasms
22
Urinary Bladder Neoplasms
21
Head and Neck Neoplasms
21
Prostatic Neoplasms
20
Esophageal Neoplasms
20
Triple Negative Breast Neoplasms
19
Colonic Neoplasms
19
Uterine Cervical Neoplasms
18
Carcinoma, Hepatocellular
17
Mesothelioma
16
Lung Diseases
13
Sarcoma
12
Parkinson Disease 4, Autosomal Dominant Lewy Body
12
Mesothelioma, Malignant
12
Cholangiocarcinoma
11
Adenocarcinoma of Lung
11
Rectal Neoplasms
10
Interventions
pembrolizumab
1
Pemetrexed
1
Cisplatin
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pathologic Processes
×
Thoracic
×
30 days
×
Clear all
NCT06119581
2026-06-03
SUNRAY-01
Eli Lilly and Company
Phase 3
Recruiting
1,264 enrolled